NCT07056569View on ClinicalTrials.gov

Post-Marketing Clinical Follow-Up Trial to Evaluate the Performance and Safety of the Medical Device 047 TD Dermatitis Cream in Adults and Children With Atopic and Contact Dermatitis Symptoms Confirmed by Clinical Parameters

NARecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 5, 2025

Primary Completion Date

August 31, 2025

Study Completion Date

September 30, 2025

Conditions

Dermatitis, ContactDermatitisDermatitis, ChronicDermatitis, EczematousDermatitis, Atopic Dermatitis

Interventions

DEVICE

047_TD Dermatitis cream twice a day for 28 days

047\_TD Dermatitis cream will be applied twice a day for 28 days on the affected skin zone in sufficient amount of cream and let it dry.

Trial Locations (3)

20154

NOT_YET_RECRUITING

Studio Medico Pigatto Bersani, Milan

27058

NOT_YET_RECRUITING

Studio Medico, Voghera

37135

RECRUITING

Poliambulatorio Verona, Verona

All Listed Sponsors

lead

Biokosmes Srl

INDUSTRY

NCT07056569 - Post-Marketing Clinical Follow-Up Trial to Evaluate the Performance and Safety of the Medical Device 047 TD Dermatitis Cream in Adults and Children With Atopic and Contact Dermatitis Symptoms Confirmed by Clinical Parameters | Biotech Hunter | Biotech Hunter